AllCells specializes in the procurement and customization of human-derived hematological tissues and services, providing high quality GMP and RUO products to aid global life science researchers and bio-manufacturing organizations in developing immunotherapies, vaccines, and cell and gene therapy starting materials.

AllCells

MyCellome LLC provides services related to cellular analysis and cell-based technologies.

MyCellome LLC

AllCells | 8,653 followers on LinkedIn. Providing the highest quality, healthy human primary cells for research. | Founded in 1998, AllCells, a Discovery Life Sciences brand, is a market-leading provider of highly characterized primary cell and tissue products, supporting global biomedical organizations seeking to develop and manufacture novel drugs and cell therapies. By providing Clinical Grade and RUO products, custom donor management services, and integrated analytical capabilities, AllCells&#39; comprehensive solutions streamline every stage of development to help bring novel therapies to market faster. Our FDA-registered, IRB-approved, AABB-compliant donor facilities strategically located across the U.S. provide access to healthy, recallable, well-characterized donors with diverse and rare demographics.

Lisa Martin

Family Nurse Practitioner & Aesthetic Nurse Practitioner

Stephani Ramirez MSN, FNP-C, RN, LE

Sr. Business Development Director at AllCells/Discovery Life Sciences

Karen Bostwick

Scientific writer | content creator | consultant | Cell & Gene therapy

Debbie King

The recording of our LinkedIn Live “Overcoming the Challenges of Allogeneic PBMC Isolation in GMP Manufacturing Workflow” is now available. Watch the replay here: https://lnkd.in/gVz6HYT3 To learn more about GMP Cryopreserved PBMCs, visit our website: https://lnkd.in/g323KhT7

Join us for this live event! #CellTherapy #GeneTherapy #Immunotherapy #GMP

Join us today for an insightful LinkedIn Live session with Dr. Yuki Kato Maves who will present a real-world case study highlighting how we partnered with a CGT developer to optimize the isolation workflow of GMP cryopreserved peripheral blood mononuclear cells (PBMCs). https://lnkd.in/gqebDYXG See you at 3pm ET / 12pm PT!

Our Alameda, California site is now AABB-accredited!

How did Discovery’s initiative with a CGT developer significantly reduce the risk of failure and CDMO costs? Tune into our upcoming LinkedIn Live event on 11/13, where Dr. Yuki Kato Maves will present a real-world case study highlighting how we partnered with a CGT developer to optimize the isolation workflow of GMP cryopreserved peripheral blood mononuclear cells (PBMCs), resulting in cost and risk reductions. Register now: https://lnkd.in/gqebDYXG

Are you planning to attend the 6th TIL Therapies Summit at the Colonnade Hotel in Boston next week? Schedule a meeting with us to learn more about how AllCells RUO and GMP products can help advance the tumor-infiltrating lymphocyte therapy development. Schedule a Meeting: https://lnkd.in/eeUYKCPp Connect with Conor Marino for more information.

Are you attending Meeting on the Mesa in Phoenix, Arizona next week? Our CGT experts are excited to meet with you! Learn more about our AllCells RUO and GMP products by arranging a meeting on the Partnering One portal, or connect with the team directly below: James Buto, MS , Angela Martinovic , Karen Bostwick We look forward to seeing you! #CGMesa24 Alliance for Regenerative Medicine

There is still time to visit us at Booth 38 during the #CARTCRSummit at the Boston Hynes Convention Center. Here are also a few snaps of the team, and a great speaking session presented by Yuki Kato Maves, PhD, Associate Director of Product Management. Karen Bostwick , Conor Marino , Angela Martinovic , McLean Collins , Andy L. Chiang

Will you be attending the CAR-TCR Summit next week in Boston? Yuki Kato Maves, PhD, of Discovery Life Sciences will be talking about PBMC isolation in GMP manufacturing workflow in the Supply chain & Clinical Operations Track on Day 1 Wed, Sep 18, 12:05 pm. Mark your calendar to attend this presentation. We are excited to meet you next week. Connect with the team: McLean Collins , Angela Martinovic , Karen Bostwick , Conor Marino , Andy L. Chiang Click here to schedule a private meeting with us: https://lnkd.in/gUCZyZCt We look forward to seeing you!

We're excited to partner with ScaleReady in the inaugural G-Rex® Grant Program—a $20M initiative aimed at advancing CGT development and manufacturing. Discovery Life Sciences specializes in leukapheresis and custom prospective collections of high-quality CGT starting materials. Through this partnership, G-Rex® Grant recipients gain access to exclusive offers on AllCells® RUO and GMP products. Learn more: https://lnkd.in/e8m5j269 Discovery’s AllCells RUO and GMP products, combined with integrated analytical services, have supported many CGT programs in transitioning from early discovery to process development and manufacturing, with an average 98% collection deliverability rate. Connect with us today to discuss your CGT projects: https://lnkd.in/gmPsEZvw #CellandGeneTherapy #CGT #ScaleReady

Metric
Company Name	AllCells	MyCellome LLC
Symbol
MSH ID	COM:ALLCELLS	COM:MYCELLOME
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Biotechnology
Country	US	US
Stage
Employee Count
Website	allcells.com	mycellome.com
LinkedIn	allcells-llc	mycellome
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	9.54K
Web Traffic Growth	-0.36
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ALLC

COM:ALLCELLS

AllCells

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue